Blueberries Medical Co. (BBRRF)

$0.01 0.00 (-4.17%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 2,100
Avg Vol 41,168
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 79%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Blueberries Medical Corp., a consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia. The company produces and distributes psychoactive and non-psychoactive cannabis derivatives. Blueberries Medical Corp. is based in Vancouver, Canada.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Address:
8500 West Georgia Street, Suite 2200, Vancouver, Canada
unsqueezedlem0n
unsqueezedlem0n Jun. 8 at 5:50 PM
$BBRRF this thing does nothing daily, yearly
1 · Reply
Payphonebob
Payphonebob May. 28 at 10:04 PM
$BBRRF Q1 2026 financial results ending 3/31/26 were just released after the closed today 5/28/26. Revenues still lower compared to same time period last year. Not good. Once again very disappointing. 🤷‍♂️
2 · Reply
LongRider830
LongRider830 May. 24 at 10:11 AM
$BBRRF Terraflos
0 · Reply
ipecac007
ipecac007 May. 22 at 11:02 PM
$BBRRF Is traceability the most important ingredient in your pharmaceutical formulation? 🔍 In the healthcare industry, the quality of an ingredient is not defined solely by its purity, but by the strength of the documentation that supports it. When evaluating a pharmaceutical CBD supplier, the real question is: Is your ingredient ready to pass audits, regulatory processes and international standards? 📋 At BLUEBERRIES, we understand that regulatory compliance is not a differential: it is the foundation of patient safety and commercial success. That is why we work on three key pillars: 🧪 Pharmaceutical Grade Documentation Complete Certificates of Analysis (CoA), technical specifications and full lot-to-lot traceability. 🌿 Transparency throughout the chain From the botanical origin to the extraction and purification process, each stage is documented under strict quality and compliance standards. 🛠️ Specialized technical and regulatory support
1 · Reply
ipecac007
ipecac007 May. 22 at 10:59 PM
$BBRRF Brazil is consolidating itself as the epicenter of innovation in Cannabis and Blueberries is present. This week, the eyes of the industry in Latin America are on São Paulo with the celebration of the Cannabis Fair, a key space where medicine, technology, cultivation and business converge in a rapidly expanding market that already exceeds 800,000 patients registered in the country. At Blueberries, we understand that the future of medicinal cannabis applications depends not only on the genetics of the plant, but on the purity and precision of the final ingredient. For this reason, our approach is aligned with the demands of a market as demanding as Brazil's: 🔬 High-Precision Medicinal Applications: We support the development of advanced treatments for human and veterinary health, where cannabinoid consistency is critical to clinical efficacy. ⚡ Supercritical CO₂ Extraction Technology: How do we achieve it? Through state-of-the-art process engineering.
0 · Reply
LongRider830
LongRider830 May. 19 at 11:47 PM
$BBRRF Found Nutripharma on Amazon: I've shared a Brand Store on Amazon with you. https://www.amazon.com/stores/NUTRIPHARMAQuickSlim/page/C10F85A5-32BA-4B9C-B0AF-52CBEAB86CC5?lp_asin=B09PZBB5Y6&ref_=cm_sw_r_apann_ast_store_RTDJ23THN98DW9ZB8MVB&store_ref=bl_ast_dp_brandlogo_sto
0 · Reply
LongRider830
LongRider830 May. 7 at 5:57 AM
$BBRRF CSE Monthly Progress Report for April 2026:
2 · Reply
Payphonebob
Payphonebob May. 5 at 12:40 PM
$BBRRF long rider, what is your opinion about financial results released on 4/28/26?
1 · Reply
Payphonebob
Payphonebob Apr. 29 at 2:23 AM
$BBRRF audited financial results came out tonight and they don’t look good. The last three months of 2025 vs 2024 revenue was down almost 90% Comparing annual revenue for 2024 versus 2025 roughly 30% less Enough said. Huge disappointment…
1 · Reply
LongRider830
LongRider830 Apr. 23 at 9:13 AM
$BBRRF Potential For Mass Success Efficiency and Consistency: In traditional agriculture, active ingredient levels fluctuate due to weather. This biotech model ensures every batch is identical, which is critical for pharmaceutical and high-end cosmetic standards. Financial Growth: Terraflos has projected roughly $20 million in earnings for 2026, with a stated growth rate of 100% annually. Market Tailwinds: The global biotechnology market is projected to reach $4.41 trillion by 2031. As consumers shift toward "clean" and "science-backed" ingredients, Terraflos is positioned to supply the molecules driving this demand.
3 · Reply
Latest News on BBRRF
No data available.
unsqueezedlem0n
unsqueezedlem0n Jun. 8 at 5:50 PM
$BBRRF this thing does nothing daily, yearly
1 · Reply
Payphonebob
Payphonebob May. 28 at 10:04 PM
$BBRRF Q1 2026 financial results ending 3/31/26 were just released after the closed today 5/28/26. Revenues still lower compared to same time period last year. Not good. Once again very disappointing. 🤷‍♂️
2 · Reply
LongRider830
LongRider830 May. 24 at 10:11 AM
$BBRRF Terraflos
0 · Reply
ipecac007
ipecac007 May. 22 at 11:02 PM
$BBRRF Is traceability the most important ingredient in your pharmaceutical formulation? 🔍 In the healthcare industry, the quality of an ingredient is not defined solely by its purity, but by the strength of the documentation that supports it. When evaluating a pharmaceutical CBD supplier, the real question is: Is your ingredient ready to pass audits, regulatory processes and international standards? 📋 At BLUEBERRIES, we understand that regulatory compliance is not a differential: it is the foundation of patient safety and commercial success. That is why we work on three key pillars: 🧪 Pharmaceutical Grade Documentation Complete Certificates of Analysis (CoA), technical specifications and full lot-to-lot traceability. 🌿 Transparency throughout the chain From the botanical origin to the extraction and purification process, each stage is documented under strict quality and compliance standards. 🛠️ Specialized technical and regulatory support
1 · Reply
ipecac007
ipecac007 May. 22 at 10:59 PM
$BBRRF Brazil is consolidating itself as the epicenter of innovation in Cannabis and Blueberries is present. This week, the eyes of the industry in Latin America are on São Paulo with the celebration of the Cannabis Fair, a key space where medicine, technology, cultivation and business converge in a rapidly expanding market that already exceeds 800,000 patients registered in the country. At Blueberries, we understand that the future of medicinal cannabis applications depends not only on the genetics of the plant, but on the purity and precision of the final ingredient. For this reason, our approach is aligned with the demands of a market as demanding as Brazil's: 🔬 High-Precision Medicinal Applications: We support the development of advanced treatments for human and veterinary health, where cannabinoid consistency is critical to clinical efficacy. ⚡ Supercritical CO₂ Extraction Technology: How do we achieve it? Through state-of-the-art process engineering.
0 · Reply
LongRider830
LongRider830 May. 19 at 11:47 PM
$BBRRF Found Nutripharma on Amazon: I've shared a Brand Store on Amazon with you. https://www.amazon.com/stores/NUTRIPHARMAQuickSlim/page/C10F85A5-32BA-4B9C-B0AF-52CBEAB86CC5?lp_asin=B09PZBB5Y6&ref_=cm_sw_r_apann_ast_store_RTDJ23THN98DW9ZB8MVB&store_ref=bl_ast_dp_brandlogo_sto
0 · Reply
LongRider830
LongRider830 May. 7 at 5:57 AM
$BBRRF CSE Monthly Progress Report for April 2026:
2 · Reply
Payphonebob
Payphonebob May. 5 at 12:40 PM
$BBRRF long rider, what is your opinion about financial results released on 4/28/26?
1 · Reply
Payphonebob
Payphonebob Apr. 29 at 2:23 AM
$BBRRF audited financial results came out tonight and they don’t look good. The last three months of 2025 vs 2024 revenue was down almost 90% Comparing annual revenue for 2024 versus 2025 roughly 30% less Enough said. Huge disappointment…
1 · Reply
LongRider830
LongRider830 Apr. 23 at 9:13 AM
$BBRRF Potential For Mass Success Efficiency and Consistency: In traditional agriculture, active ingredient levels fluctuate due to weather. This biotech model ensures every batch is identical, which is critical for pharmaceutical and high-end cosmetic standards. Financial Growth: Terraflos has projected roughly $20 million in earnings for 2026, with a stated growth rate of 100% annually. Market Tailwinds: The global biotechnology market is projected to reach $4.41 trillion by 2031. As consumers shift toward "clean" and "science-backed" ingredients, Terraflos is positioned to supply the molecules driving this demand.
3 · Reply
LongRider830
LongRider830 Apr. 19 at 10:48 PM
$BBRRF Amazing where this company is going - one day biotechnology could explode similar to AI:
0 · Reply
Payphonebob
Payphonebob Apr. 14 at 2:55 PM
$BBRRF last week and this week as of this moment, I’ve picked up additional 300,000 shares of BBRRF at $0.0100 (3 pieces at 100,000 at 0.01 All or none). Full year 2025 audited financials should be released by April 30th per past history. Last year (early March 2025) they issued more shares because they needed more money to run the company aka dilution. They did not do that this year and the director is keeping his word and buying shares at one cent randomly when the stock drops below one cent. My thinking is that the revenue will finally pick up because if it doesn’t, then why would the director continue to buy shares at one cent knowing they’re gonna tank (share price) once earnings are released. Let’s hope our patience will finally be rewarded 🤞
1 · Reply
unsqueezedlem0n
unsqueezedlem0n Apr. 14 at 12:04 AM
$BBRRF cfo continues to buy 10k and 50k cllips of shares
3 · Reply
Payphonebob
Payphonebob Apr. 6 at 5:08 PM
$BBRRF Last week Terraflos/Facundo Garreton (at Harvard entrepreneur retreat event) was voted #1 out 136 companies presenting…. Hoping this helps blueberries medical stock price BBRRF which has been stuck around $0.0111 the past 9 months Deep science demands solid strategies. This week at Harvard, we were recognized as the best company and best strategy among 136 global companies. This milestone transcends the award, validates our operating model. Scaling biotechnology and redesigning human longevity requires much more than laboratory discoveries; It requires an infrastructure capable of transforming scientific knowledge into real and scalable value. The recognition belongs to our Network of Teams. It confirms that when clear scientific vision is combined with talent and consistency in execution, the results set the industry standard. Thank you for representing us so magnificently Facundo Garretón 👏 #Terraflos #Harvard #ConsumerScience #DeepTech #Longevity #NetworkOfTeams
2 · Reply
LongRider830
LongRider830 Apr. 6 at 12:13 PM
$BBRRF CSE Monthly Progress Report for March 2026:
0 · Reply
ipecac007
ipecac007 Apr. 5 at 10:19 PM
$BBRRF Blueberries Medical Corp.Blueberries Medical Corp. 7,232 followers7,232 followers 4d • 4 days ago • Visible to anyone on or off LinkedIn Follow Science alone does not scale. In Blueberries Medical Corp., we work to convert research into real production capacity: processes, scaling and production of new generation ingredients with an industrial focus. That is our role within Terraflos Inc.: to be the center of scaling and production where scientific knowledge is transformed into functional, viable and reproducible solutions. Because in biotechnology, discovery is just the beginning. The real value is in bringing that innovation to production with consistency, efficiency and market vision. This is how we promote ingredients aligned with the great global demands in longevity, well-being and sustainability. The future does not belong only to those who research. It belongs to those who can transform science into scalable production.
1 · Reply
ipecac007
ipecac007 Mar. 30 at 10:58 PM
$BBRRF Blueberries Medical Corp.Blueberries Medical Corp. 7,227 followers7,227 followers 2w • 2 weeks ago • Visible to anyone on or off LinkedIn Follow CBD in Argentine Cosmetics: Purity, Scientific Rigor and ANMAT Compliance with Blueberries Medical. The cosmetics industry in Argentina is undergoing an unprecedented transformation. Since ANMAT's Provision 8504/2021, the path has been traced: Cannabidiol (CBD) is a legitimate, safe and high-value ingredient for personal hygiene and cosmetic products. At Blueberries Medical Corp, we understand that for local labs, the key is in CBD Isolate. Why is it the preferred option of our allies in Argentina? ✅ Strict Compliance: With trace amounts of THC less than 0.2%, we guarantee that your final product will pass any ANMAT. ✅ Formulation Versatility: Being a crystalline powder with +99% purity, it does not alter the color or aroma of your creams, serums or lotions. ✅ Guaranteed Stability: Ideal for industrial processes that require technical precision.
2 · Reply
LongRider830
LongRider830 Mar. 14 at 4:21 AM
$BBRRF Welcome to the ecosystem, team @rubisco_biotechnology This is just getting started
1 · Reply
unsqueezedlem0n
unsqueezedlem0n Mar. 14 at 3:52 AM
$BBRRF another acquisiton for facundo ? Check the ig pages of facundo and terraflos
1 · Reply
LongRider830
LongRider830 Mar. 12 at 4:45 PM
$BBRRF Colombia is rapidly becoming a global hub for cannabis cultivation and export, encouraged by government policies that prioritize regulatory clarity and international partnerships. https://news.budlords.com/post/south-america-embraces-cannabis-as-an-economic-powerhouse-amid-us-market-hesitancy
1 · Reply
ipecac007
ipecac007 Mar. 7 at 1:05 AM
$BBRRF Medical cannabis: the pharmaceutical market in LATAM continues to advance The pharmaceutical industry is experiencing a key moment: more and more countries are strengthening their regulatory frameworks to enable the development of cannabis-based products with scientific backing, traceability and compliance. Brazil is a clear example of this progress, opening up new opportunities for companies looking for reliable ingredients aligned with regulation. At Blueberries, we have all the required licenses and permits, we operate under quality standards and comply with the necessary regulations to export, including the Brazilian market.
2 · Reply
LongRider830
LongRider830 Mar. 3 at 4:40 PM
$BBRRF CSE Monthly Progress Report for February 2026:
0 · Reply